XOMA
NASDAQXOMA Royalty Corporation
News · 26 weeks74-93%
2026-03-012026-08-23
Mix3690d
- SEC Filings19(53%)
- Insider11(31%)
- Other4(11%)
- Dividends1(3%)
- Offering1(3%)
Latest news
25 items- SECAmendment: SEC Form SCHEDULE 13G/A filed by XOMA Royalty CorporationSCHEDULE 13G/A - XOMA Royalty Corp (0000791908) (Subject)
- SECAmendment: SEC Form SCHEDULE 13G/A filed by XOMA Royalty CorporationSCHEDULE 13G/A - XOMA Royalty Corp (0000791908) (Subject)
- SECSEC Form 15-12G filed by XOMA Royalty Corporation15-12G - XOMA Royalty Corp (0000791908) (Filer)
- SECSEC Form EFFECT filed by XOMA Royalty CorporationEFFECT - XOMA Royalty Corp (0000791908) (Filer)
- SECSEC Form S-8 POS filed by XOMA Royalty CorporationS-8 POS - XOMA Royalty Corp (0000791908) (Filer)
- SECSEC Form S-8 POS filed by XOMA Royalty CorporationS-8 POS - XOMA Royalty Corp (0000791908) (Filer)
- SECSEC Form S-8 POS filed by XOMA Royalty CorporationS-8 POS - XOMA Royalty Corp (0000791908) (Filer)
- SECSEC Form S-8 POS filed by XOMA Royalty CorporationS-8 POS - XOMA Royalty Corp (0000791908) (Filer)
- SECSEC Form S-8 POS filed by XOMA Royalty CorporationS-8 POS - XOMA Royalty Corp (0000791908) (Filer)
- SECSEC Form S-8 POS filed by XOMA Royalty CorporationS-8 POS - XOMA Royalty Corp (0000791908) (Filer)
- SECSEC Form S-8 POS filed by XOMA Royalty CorporationS-8 POS - XOMA Royalty Corp (0000791908) (Filer)
- SECSEC Form S-8 POS filed by XOMA Royalty CorporationS-8 POS - XOMA Royalty Corp (0000791908) (Filer)
- SECSEC Form S-8 POS filed by XOMA Royalty CorporationS-8 POS - XOMA Royalty Corp (0000791908) (Filer)
- SECSEC Form S-8 POS filed by XOMA Royalty CorporationS-8 POS - XOMA Royalty Corp (0000791908) (Filer)
- SECSEC Form S-8 POS filed by XOMA Royalty CorporationS-8 POS - XOMA Royalty Corp (0000791908) (Filer)
- SECSEC Form S-8 POS filed by XOMA Royalty CorporationS-8 POS - XOMA Royalty Corp (0000791908) (Filer)
- SECSEC Form S-8 POS filed by XOMA Royalty CorporationS-8 POS - XOMA Royalty Corp (0000791908) (Filer)
- SECSEC Form S-8 POS filed by XOMA Royalty CorporationS-8 POS - XOMA Royalty Corp (0000791908) (Filer)
- SECSEC Form POS AM filed by XOMA Royalty CorporationPOS AM - XOMA Royalty Corp (0000791908) (Filer)
- INSIDERSEC Form 4 filed by Large owner Bvf Partners L P/Il4 - XOMA Royalty Corp (0000791908) (Issuer)
- INSIDERChief Legal Officer Montano Maricel Perea disposed of 42,371 shares, closing all direct ownership in the company (SEC Form 4) to cover withholding tax4 - XOMA Royalty Corp (0000791908) (Issuer)
- INSIDERDirector Limber Joseph M disposed of 9,532 shares, returned 10,000 units of 8.625% Series A Cumulative Perpetual Preferred Stock to the company and returned 20,000 units of Depositary Shares - 8.375% Series B Cumulative Stock to the company, closing all direct ownership in the company (SEC Form 4) (tax withholding)4 - XOMA Royalty Corp (0000791908) (Issuer)
- INSIDERChief Investment Officer Sitko Bradley disposed of 86,702 shares, returned 395 units of 8.625% Series A Cumulative Perpetual Preferred Stock to the company and returned 9,045 units of Depositary Shares - 8.375% Series B Cumulative Stock to the company, closing all direct ownership in the company (SEC Form 4) to cover withholding tax4 - XOMA Royalty Corp (0000791908) (Issuer)
- INSIDERChief Executive Officer Hughes Owen disposed of 192,016 shares and returned 102,000 units of Depositary Shares - 8.375% Series B Cumulative Stock to the company, closing all direct ownership in the company (SEC Form 4) (tax withholding)4 - XOMA Royalty Corp (0000791908) (Issuer)
- INSIDERDirector Kosacz Barbara disposed of 6,269 shares, closing all direct ownership in the company (SEC Form 4) to cover taxes4 - XOMA Royalty Corp (0000791908) (Issuer)
XOMA FAQ
7 questionsWhat does XOMA Royalty Corporation do?
XOMA Corporation, a biotech royalty aggregator, discovers and develops therapeutic candidates in the United States, Europe, and the Asia Pacific. The company has a pipeline of monoclonal antibodies and technologies to license to pharmaceutical and biotechnology companies to further their clinical development. Its proprietary product candidates include PTH1R program, an anti-parathyroid receptor pipeline to address unmet medical needs, including primary hyperparathyroidism and humoral hypercalcemia of malignancy; XMetA, an insulin receptor-activating antibody to provide long-acting reduction...Where does XOMA stock trade?
XOMA Royalty Corporation (XOMA) is listed on NASDAQ.What sector and industry is XOMA in?
XOMA Royalty Corporation operates in the Health Care sector, Biotechnology: Pharmaceutical Preparations industry.When did XOMA Royalty Corporation go public?
XOMA Royalty Corporation (XOMA) completed its IPO in 1986.What are analysts saying about XOMA?
XOMA Royalty Corporation has had 7 recent analyst actions on file. The most recent action was from The Benchmark Company: Buy with a $3500.00 price target on 2025-04-17. Recent price targets range from $2200.00 to $4000.00.What companies are similar to XOMA?
Notable peers in the same industry include RZLT (Rezolute Inc.), PALI (Palisade Bio Inc.), YTEN (Yield10 Bioscience Inc.). Compare XOMA side-by-side with any of them on Quantisnow.How can I track XOMA on Quantisnow?
Quantisnow aggregates XOMA Royalty Corporation's SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow XOMA to receive live email and push alerts on every new disclosure.